UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 12b-25  

 

NOTIFICATION OF LATE FILING  

 

    ☐ Form 10-K   ☐ Form 20-F   ☐  Form 11-K   ☒ Form 10-Q   ☐ Form 10-D    ☐ Form N-SAR    ☐ Form N-CSR
     
    For Period Ended: March 31, 2017
     
    ☐   Transition Report on Form 10-K
    ☐   Transition Report on Form 20-F
    ☐   Transition Report on Form 11-K
    ☐   Transition Report on Form 10-Q
    ☐   Transition Report on Form N-SAR
     
    For the Transition Period Ended:                                                

 

Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

 

If the notification relates to a portion of the filing checked above, identify the item(s) to which the notification relates:____________________________________________________________________________

 

PART I - REGISTRANT INFORMATION

 

Immudyne, Inc.
Full name of registrant
 
 
Former name if applicable:
 
50 Spring Meadow Road
Address of principal executive office
 
Mt. Kisco, NY 10549
City, state and zip code

 

  

 

 

PART II - RULES 12b-25 (b) AND (c)

 

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25 (b), the following should be completed. (Check box if appropriate.)

 

(a) The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;

 

(b) The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and

 

(c) The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

 

PART III - NARRATIVE

 

State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition report portion thereof, could not be filed within the prescribed time period.

 

The Company requires additional time to complete its quarterly end procedures. Those procedures could not be completed without incurring undue hardship and expense.

 

PART IV - OTHER INFORMATION

 

(1) Name and telephone number of person to contact in regard to this notification.

 

  Mark McLaughlin   (914)   244-1777
   (Name)   (Area Code)   (Telephone Number)

 

(2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If the answer is no, identify report(s). ☒ Yes   ☐ No

 

(3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? ☒ Yes   ☐ No

 

If so: attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

 

In the first quarter of 2017 we invested considerable time and Company resources into the preparation for launch of our in-licensed patented hair loss shampoo, conditioner, and leave in foam which we believe will provide meaningful contributions to our business in the near future. We also began investing additional time and Company resources into an internal media strategy that has already begun to positively impact our business. Both of these trends impacted our overall sales in the first quarter of 2017, which we currently estimate to be approximately $438,000. However, we believe these changes to our business will drive the Company's long-term success.

 

 2 

 

 

Immudyne, Inc.

(Name of Registrant as Specified in Charter)

 

has caused this notification to be signed on its behalf by the undersigned thereunto duly authorized.

 

Date: June 7, 2017 By: /s/ Mark McLaughlin
  Name: Mark McLaughlin
  Title: Chief Executive Officer

 

 

 

3